COG vs. KOO, RENX, INHC, TRLS, IQAI, FDBK, DVRG, SENS, EMIS, and CRW
Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Kooth (KOO), Renalytix (RENX), Induction Healthcare Group (INHC), Trellus Health (TRLS), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.
Cambridge Cognition vs.
Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability.
Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.
In the previous week, Kooth's average media sentiment score of 0.59 beat Cambridge Cognition's score of 0.00 indicating that Kooth is being referred to more favorably in the media.
Cambridge Cognition received 94 more outperform votes than Kooth when rated by MarketBeat users. However, 91.67% of users gave Kooth an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.
Kooth has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500.
Kooth currently has a consensus price target of GBX 583.33, suggesting a potential upside of 286.57%. Given Kooth's stronger consensus rating and higher probable upside, research analysts clearly believe Kooth is more favorable than Cambridge Cognition.
65.0% of Kooth shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 17.3% of Kooth shares are owned by company insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Kooth has a net margin of 7.89% compared to Cambridge Cognition's net margin of -10.07%. Kooth's return on equity of 18.59% beat Cambridge Cognition's return on equity.
Summary
Kooth beats Cambridge Cognition on 13 of the 17 factors compared between the two stocks.
Get Cambridge Cognition News Delivered to You Automatically
Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cambridge Cognition Competitors List
Related Companies and Tools
This page (LON:COG) was last updated on 2/22/2025 by MarketBeat.com Staff
